In studies using APPswe/PSEN1dE9 models, the adoptive transfer of Abeta-specific Th1 cells, unlike Th2 or Th17 cell transfers, led to worsened AD pathology, heightened microglial activation, and compromised cognitive abilities [149]. This evidence concerns the gene APP and Alzheimer disease.